AXIOS July 29, 2024
The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second most common cause of U.S. cancer deaths.
Why it matters: More than 1 out of 3 eligible Americans don’t complete screening methods such as colonoscopy or a stool test, and a simple blood draw for the condition could be incorporated into routine physicals.
Yes, but: The Shield test from Guardant has limited detection of early stage colorectal cancer and does not detect 87% of precancerous growths. It’s not viewed as a replacement for a diagnostic colonoscopy.
State of play: Shield is expected to launch within the next week — and the FDA...
Today's Sponsors
Today's Sponsor